
Opinion|Videos|November 15, 2024
First Line Treatment Decisions for Age-Related Macular Degeneration
Key Takeaways
Sumit Sharma, MD, FASRS asks the panel what they are using for first-line AMD treatment and what considerations factor into decision making, such as insurance coverage or risk of inflammation.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Reasoning prompts sharpen multimodal AI on bilingual ophthalmology exam questions
2
Phase 3 NORTHSTAR trial launches for gildeuretinol in stargardt disease
3
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
4
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
5





















